Coexistent Anaplastic and Differentiated Thyroid Carcinoma. 2006

Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
Central Laboratory for Clinical Investigation, Miyazaki University Hospital, Miyazaki, Japan.

The aim of the present study was to clarify the underlying molecules that might contribute to the highly aggressive behavior of anaplastic thyroid carcinoma. We selected 5 cases of anaplastic thyroid carcinoma that had a differentiated area to determine differences in the molecules of undifferentiated and differentiated cancer cells. We immunohistochemically examined the localization of nuclear antigen (Ki-67), proliferating cell nuclear antigen (PCNA), p53, apoptotic protease-activating factor-1 (Apaf-1), CD26, galectin-3, E-cadherin, and CD147. We found an increased Ki-67, PCNA, and p53 labeling indices; decreased levels of Apaf-1, CD26, galectin-3, and E-cadherin; and overexpression of CD147 in the undifferentiated area compared with the differentiated area. These findings indicate high proliferative properties, suppression of apoptosis, disruption of cell-cell interaction, and induction of matrix metalloproteinases in the undifferentiated areas. Thus the molecules examined might be useful for evaluating the aggressive nature of this tumor and the prognosis.

UI MeSH Term Description Entries

Related Publications

Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
November 2007, Nihon rinsho. Japanese journal of clinical medicine,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
January 1997, Anticancer research,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
February 2023, The Laryngoscope,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
January 2009, International journal of health sciences,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
January 1988, Archives of otolaryngology--head & neck surgery,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
September 2016, Endocrine pathology,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
January 1982, The Yale journal of biology and medicine,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
September 1984, Gan no rinsho. Japan journal of cancer clinics,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
March 2024, The journal of pathology. Clinical research,
Yatsuki Aratake, and Hajime Nomura, and Tomio Kotani, and Kosuke Marutsuka, and Kaoru Kobayashi, and Kanji Kuma, and Akira Miyauchi, and Akihiko Okayama, and Akihiko Okayama
April 2006, Cancer control : journal of the Moffitt Cancer Center,
Copied contents to your clipboard!